Yüklüyor......
Efinaconazole in the treatment of onychomycosis
Efinaconazole 10% topical solution is a new triazole recently approved for the treatment of onychomycosis. It inhibits fungal lanosterol 14α-demethylase in the ergosterol biosynthesis pathway, has potent antifungal activity against dermatophytes, as well as activity against Candida spp. and non-derm...
Kaydedildi:
| Yayımlandı: | Infect Drug Resist |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4459619/ https://ncbi.nlm.nih.gov/pubmed/26082652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S69596 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|